HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS- A BRAZILIAN REAL WORLD STUDY.

Author(s)

Decimoni TC1, Sztajnbok S1, Feitosa MR2, Parra RS2
1Takeda Pharmaceuticals Brazil, São Paulo, Brazil, 2Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto – USP, Ribeirão Preto, Brazil

OBJECTIVES: Describe the use of health resources related to the management of moderate to severe ulcerative colitis (UC) in Brazil.

METHODS: This was a retrospective analysis that collected data from patient medical records in multiple Brazilian centres in 2017. Healthcare resource utilization data related to the management of patients (≥18 years old) diagnosed with moderate to severe UC at least 6 months before the inclusion day were presented using descriptive statistics.

RESULTS: A total of 143 patients with moderate to severe UC were included in this analysis. The mean age was 45.9±13.83 years and 56.6% were female. The mean weight and body mass index were 70.1±14.33 kg and 25.7±4.63 kg/m2, respectively. The time since diagnosis of moderate to severe UC was on average 6.1±4.85 years. Surgeries were required in 2.8% of patients and the average number of surgeries per patient was 1.8±0.5. Total colectomy and closure of enterostomy (any segment) corresponded (each one) to 28.6% of surgeries. The mean number of hospitalizations was 1.5±0.92 times for UC; the mean duration was 0.7 months. The mean number of medical appointments per patient was 10.8±6.56 during the period and 92.5% corresponded to an IBD specialist visit. The average number of imaging and laboratory tests was 17.8±14.02. Hemogram was the most frequent test performed (38.8%), followed by C-reactive protein (29.8%). Salicylic acid derivatives were the main type of therapy prescribed after the disease diagnosis (60.3%), followed by biological therapy (10.6%).

CONCLUSIONS: Moderate to severe UC was associated with substantial healthcare resource utilization in Brazil.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PGI30

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Gastrointestinal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×